Navigation Links
Conversion of brain tumor cells into blood vessels thwarts treatment efforts
Date:1/24/2011

ng initially successful, anti-angiogenic therapy ultimately fails in glioblastomas," says Verma.

Avastin interrupts normal blood vessels, but eventually they are replaced with tumor-derived vessels, which are now treatment-resistant. "Once again, we are confronted with the versatility of tumor cells, which allows them to survive and thrive under adverse conditions," says Verma. "But as we learn more about tumors' molecular flexibility, we will be able to design novel, tailor-made combination therapies to combat deadly brain tumors."


'/>"/>

Contact: Gina Kirchweger
Kirchweger@salk.edu
858-453-410-01340
Salk Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Brown University chemists simplify biodiesel conversion
2. Mount Sinai researchers discover new mechanism behind cellular energy conversion
3. New microbial genetic system dissects biomass to biofuel conversion
4. New molecule could save brain cells from neurodegeneration, stroke
5. Reducing diet early in pregnancy stunts fetal brain development
6. New technique to see neurons of the deep brain for months at a time developed at Stanford
7. LCD projector used to control brain and muscles of tiny organisms such as worms
8. Researchers show how Alzheimers plaques lead to loss of nitric oxide in brain
9. New book highlights the cellular and molecular determinants of brain wiring
10. Major advance in MRI allows much faster brain scans
11. UTHealth studies cord blood stem cells for pediatric traumatic brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Conversion of brain tumor cells into blood vessels thwarts treatment efforts
(Date:4/8/2015)... April 8, 2015  Infinisource, a leading provider ... and Morpho, a leading supplier of biometric identification ... the market,s most advanced biometrically-enabled time clock, the ... time clock is setting a bold, new standard ... for the small and mid-size employer. When connected ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
... through which it can protect itself against newly-developing cancer ... in our organs every day. Once tumours have developed, ... from the immune system. Scientists from the research group ... (HZI) in Braunschweig have now succeeded to reveal a ...
... in the lungs of people who smoke may offer a ... emphysema before the disease damages and eventually destroys areas of ... The study found that smokers who have very subtle signs ... different blood flow patterns in their lungs compared to non-smokers ...
... April 6, 2010 Chronix Biomedical today announced publication ... serum DNA blood tests to predict clinical status and ... sclerosis (MS). Chronix Biomedical uses proprietary technology to ... that is released into the bloodstream by damaged and ...
Cached Biology News:The immune system's guard against cancer 2The immune system's guard against cancer 3New test could identify smokers at risk of emphysema 2Chronix Biomedical's serum DNA assays monitor disease activity and treatment response in MS 2Chronix Biomedical's serum DNA assays monitor disease activity and treatment response in MS 3
(Date:5/1/2015)... , May 1, 2015 Pfenex ... engaged in the development of biosimilar therapeutics including ... today that its first quarter 2015 financial results ... before the open of market. At 8:30 am Eastern ... to discuss the financial results and provide a ...
(Date:5/1/2015)... 2015 Investor-Edge has initiated ... (NASDAQ: GENE ), Agilent Technologies Inc. (NYSE: ... TMO ), Sequenom Inc. (NASDAQ: SQNM ... Free research report on Genetic Technologies can be ... 30, 2015, the NASDAQ Composite ended at 4,941.42, ...
(Date:5/1/2015)... RESEARCH TRIANGLE PARK, N.C. , May 1, 2015 /PRNewswire/ ... Roger Jeffs , Ph.D., President and Co-Chief Executive Officer ... the company,s business at the Deutsche Bank 40 th ... . The presentation will take place on Wednesday, ... be accessed via a live webcast on the United Therapeutics ...
(Date:4/30/2015)... DIEGO , April 30, 2015   Tamir ... announced today an update on its Ebola antiviral therapy ... Tamir,s leading candidates, TMR004, is currently being evaluated and ... of the battle against Ebola. During the first quarter ... And Leadership Meeting To Accelerate The Evaluation of Potential ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 3Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 4Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 5Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4
... the developing world could reduce the environmental impact of ... writing today in the Inderscience publication, International Journal of ... the developing world are encouraged to compost our garden ... bin and not all of us are willing or ...
... DENVER, Sept. 18 The future of health ... integrated into practice and,health policy. But putting research ... slow the pace of cutting-edge care. Kaiser,Permanente Colorado ... aimed at getting research into practice and policy ...
... Sept. 18 Kosan Biosciences,Incorporated (Nasdaq: KOSN ) ... and Chief Financial Officer, will present at the 2007,UBS ... Grand Hyatt on,Tuesday, September 25, 2007 at 10:00 a.m. ... of the presentation by,visiting the "Events Calendar" page under ...
Cached Biology Technology:Landfill Mining 2Kaiser Permanente Colorado Opens Center for Health Dissemination and Implementation Research 2Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference 2
... product contains 5 ml Dynabeads® ... the monoclonal BerEP4 against the ... cell adhesion molecule). Also available ... 2 x 10e7 MNC in ...
albumin from bovine serum (BSA), tetramethylrhodamine conjugate...
Superior homology search software - in all the flavours of blast, with increased sensitivity and speed...
... Processing mini Tray (3 per pack), ... staining and blot processing.Automated staining of ... proteins and nucleic acid analysis.Prepares blots ... chromogenic detection.Programmable control of protocol, solution, ...
Biology Products: